Anita Treohan

Corporate Officer/Principal at AVROBIO, INC.

Health Technology

Consumer Services

Profile

Anita Treohan is currently working as the VP-Clinical Development Operations at Avrobio, Inc. Previously, she worked as the Director-Clinical Operations at ImmusanT, Inc. She completed her graduate degree at Boston University and her undergraduate degree at Emory University.

Anita Treohan active positions

Companies	Position	Start
AVROBIO, INC.	Corporate Officer/Principal	-

All active positions of Anita Treohan

Former positions of Anita Treohan

Companies	Position	End
ImmusanT, Inc. ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-

See the detail of Anita Treohan's experience

Training of Anita Treohan

Emory University	Undergraduate Degree
Boston University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anita Treohan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AVROBIO, INC.	Health Technology

Private companies	1
ImmusanT, Inc. ImmusanT, Inc. Medical SpecialtiesHealth Technology ImmusanT, Inc. develops a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Its Epitope-Specific Immuno-Therapy platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. The firm’s product Nexvax2, protects celiac disease patients against the debilitating effects of gluten. The company was by Leslie J. Williams and Robert P. Anderson founded in December 2010 and is headquartered in Cambridge, MA.	Health Technology